Cargando…
Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh
Ruthenium-103 is the parent isotope of (103m)Rh (t(1/2) 56.1 min), an isotope of interest for Auger electron therapy. During the proton irradiation of thorium targets, large amounts of (103)Ru are generated through proton induced fission. The development of a two part chemical separation process to...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741265/ https://www.ncbi.nlm.nih.gov/pubmed/29272318 http://dx.doi.org/10.1371/journal.pone.0190308 |
_version_ | 1783288171762548736 |
---|---|
author | Mastren, Tara Radchenko, Valery Hopkins, Philip D. Engle, Jonathan W. Weidner, John W. Copping, Roy Brugh, Mark Nortier, F. Meiring Birnbaum, Eva R. John, Kevin D. Fassbender, Michael Ernst-Heinrich |
author_facet | Mastren, Tara Radchenko, Valery Hopkins, Philip D. Engle, Jonathan W. Weidner, John W. Copping, Roy Brugh, Mark Nortier, F. Meiring Birnbaum, Eva R. John, Kevin D. Fassbender, Michael Ernst-Heinrich |
author_sort | Mastren, Tara |
collection | PubMed |
description | Ruthenium-103 is the parent isotope of (103m)Rh (t(1/2) 56.1 min), an isotope of interest for Auger electron therapy. During the proton irradiation of thorium targets, large amounts of (103)Ru are generated through proton induced fission. The development of a two part chemical separation process to isolate (103)Ru in high yield and purity from a proton irradiated thorium matrix on an analytical scale is described herein. The first part employed an anion exchange column to remove cationic actinide/lanthanide impurities along with the majority of the transition metal fission products. Secondly, an extraction chromatographic column utilizing diglycolamide functional groups was used to decontaminate (103)Ru from the remaining impurities. This method resulted in a final radiochemical yield of 83 ± 5% of (103)Ru with a purity of 99.9%. Additionally, measured nuclear reaction cross sections for the formation of (103)Ru and (106)Ru via the (232)Th(p,f)(103,106)Ru reactions are reported within. |
format | Online Article Text |
id | pubmed-5741265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-57412652018-01-09 Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh Mastren, Tara Radchenko, Valery Hopkins, Philip D. Engle, Jonathan W. Weidner, John W. Copping, Roy Brugh, Mark Nortier, F. Meiring Birnbaum, Eva R. John, Kevin D. Fassbender, Michael Ernst-Heinrich PLoS One Research Article Ruthenium-103 is the parent isotope of (103m)Rh (t(1/2) 56.1 min), an isotope of interest for Auger electron therapy. During the proton irradiation of thorium targets, large amounts of (103)Ru are generated through proton induced fission. The development of a two part chemical separation process to isolate (103)Ru in high yield and purity from a proton irradiated thorium matrix on an analytical scale is described herein. The first part employed an anion exchange column to remove cationic actinide/lanthanide impurities along with the majority of the transition metal fission products. Secondly, an extraction chromatographic column utilizing diglycolamide functional groups was used to decontaminate (103)Ru from the remaining impurities. This method resulted in a final radiochemical yield of 83 ± 5% of (103)Ru with a purity of 99.9%. Additionally, measured nuclear reaction cross sections for the formation of (103)Ru and (106)Ru via the (232)Th(p,f)(103,106)Ru reactions are reported within. Public Library of Science 2017-12-22 /pmc/articles/PMC5741265/ /pubmed/29272318 http://dx.doi.org/10.1371/journal.pone.0190308 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Mastren, Tara Radchenko, Valery Hopkins, Philip D. Engle, Jonathan W. Weidner, John W. Copping, Roy Brugh, Mark Nortier, F. Meiring Birnbaum, Eva R. John, Kevin D. Fassbender, Michael Ernst-Heinrich Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh |
title | Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh |
title_full | Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh |
title_fullStr | Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh |
title_full_unstemmed | Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh |
title_short | Separation of (103)Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide (103m)Rh |
title_sort | separation of (103)ru from a proton irradiated thorium matrix: a potential source of auger therapy radionuclide (103m)rh |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741265/ https://www.ncbi.nlm.nih.gov/pubmed/29272318 http://dx.doi.org/10.1371/journal.pone.0190308 |
work_keys_str_mv | AT mastrentara separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh AT radchenkovalery separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh AT hopkinsphilipd separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh AT englejonathanw separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh AT weidnerjohnw separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh AT coppingroy separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh AT brughmark separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh AT nortierfmeiring separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh AT birnbaumevar separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh AT johnkevind separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh AT fassbendermichaelernstheinrich separationof103rufromaprotonirradiatedthoriummatrixapotentialsourceofaugertherapyradionuclide103mrh |